Submission Details
| 510(k) Number | K212461 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2021 |
| Decision Date | March 15, 2022 |
| Days to Decision | 221 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K212461 is an FDA 510(k) clearance for the VITEK MS PRIME, a Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates (Class II — Special Controls, product code QBN), submitted by bioMerieux, Inc. (Hazelwood, US). The FDA issued a Cleared decision on March 15, 2022, 221 days after receiving the submission on August 6, 2021. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3378.
| 510(k) Number | K212461 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 06, 2021 |
| Decision Date | March 15, 2022 |
| Days to Decision | 221 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | QBN — Mass Spectrometry, Maldi Tof, Microorganism Identification, Cultured Isolates |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3378 |
| Definition | The Maldi Biotyper Ca System Is A Mass Spectrometer System Using Matrix-assisted Laser Desorption/ionization - Time Of Flight (maldi-tof) For The Identification And Differentiation Of Microorganisms Cultured From Human Specimens. The Maldi Biotyper Ca System Is A Qualitative In Vitro Diagnostic Device Indicated For Use In Conjunction With Other Clinical And Laboratory Findings To Aid In The Diagnosis Of Bacterial And Fungal Infections. |